Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening

BACKGROUND: According to international guidelines, HPV DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or more severe lesions. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacobellis, Michela, Violante, Cecilia, Notarachille, Gabriella, Simone, Angela, Scarfì, Rosa, Giuffrè, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859641/
https://www.ncbi.nlm.nih.gov/pubmed/29558950
http://dx.doi.org/10.1186/s12985-018-0965-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859641/
https://www.ncbi.nlm.nih.gov/pubmed/29558950
http://dx.doi.org/10.1186/s12985-018-0965-z

Ejemplares similares